Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > September 2023 Financing

<< Previous

Bullboard Posts

Next >>

Comment by O12009on Jan 12, 2024 6:15pm

206 Views

Post# 35824572

RE:RE:RE:RE:RE:RE:RE:September 2023 Financing

At .39 I will exercise all that I have to break even . We need all the shareholders and everyone that is interested in bringing the cure for cancer to the many that are left with no options, to exercise all of their warrants. It is the only way that we can keep the manipulation from winning the day and bring this great cure to market.

GLT the longs and the patients

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks